VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Johnson & Johnson vs Safran
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Johnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisSafran
SAF · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Safran leads (74 / 100 vs 61 / 100 for Johnson & Johnson).
- Segment focus: Johnson & Johnson has 2 segments (64.1% in Innovative Medicine); Safran has 3 segments (50% in Propulsion).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Johnson & Johnson has 5 moat types across 3 domains; Safran has 8 across 3.
Primary market context
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.1%
Safran
Propulsion
Aircraft propulsion (commercial, military and helicopter engines) and engine aftermarket (spares, MRO, RPFH)
Global
Aircraft OEMs, airlines/lessors, MRO operators, and militaries
Engine OEM + aftermarket service provider (incl. CFM JV participation)
50%
Side-by-side metrics
Moat coverage
Shared moat types
Johnson & Johnson strengths
Safran strengths
Segment mix
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Safran segments
Full profile >Propulsion
Oligopoly
Equipment & Defense
Oligopoly
Aircraft Interiors
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.